Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12610770 | 1.00 | SLC1A3 (0.45) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL12610806 | 0.86 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TSHRTP53 | |
| SCHEMBL12610812 | 0.86 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TSHRTP53 | |
| SCHEMBL22688963 | 0.84 | TSHR (0.43) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL29455702 | 0.84 | TSHR (0.43) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL11503365 | 0.82 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL2932038 | 0.82 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL10146952 | 0.82 | TSHR (0.41) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL28912115 | 0.79 | TSHR (0.35) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 | |
| SCHEMBL3922086 | 0.79 | TSHR (0.35) | SLC1A3SLC1A2SLC1A1TSHRCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667784-B2 | Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-06-06 | — | — | US | disclosed |
| US-20190153212-A1 | COPOLYMERS INCLUDING CINCHONA ALKALOID COMPONENTS AND ONE OR MORE ACRYLAMIDE OR ACRYLATE CONTAINING COMPONENTS, COMPLEXES CONTAINING THE SAME, AND METHODS OF USING THE SAME | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667784-B2 | Copolymers including cinchona alkaloid components and one or more acrylamide or acrylate containing components, complexes containing the same, and methods of using the | BRCA1, DCLRE1A, NIPSNAP3A | SLC1A3 1082/4885SLC1A2 1194/4885SLC1A1 489/4885 |
| US-20190153212-A1 | COPOLYMERS INCLUDING CINCHONA ALKALOID COMPONENTS AND ONE OR MORE ACRYLAMIDE OR ACRYLATE CONTAINING COMPONENTS, COMPLEXES CONTAINING THE SAME, AND METHODS OF USING THE SAME | PCNA, NCLN, CROCC | SLC1A3 1366/4885SLC1A2 1727/4885SLC1A1 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.